Skye Bioscience Shares Are Trading Higher After the Company Announced the Debut of Its "Anatomy of Progress" Nimacimab Development Update Video Series and Availability of Presentations Related to the Development of Its Anti-obesity Drug, Nimacimab.

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.